Third-Line Jevtana Improves Progression-Free Survival in Prostate Cancer Subtype
October 7th 2019"Sequential treatment in prostate cancer is really something that’s evolving over time," Dr. Daniel Petrylak said of the study findings presented at the European Society of Medical Oncology Congress 2019.
Read More